Journal: Frontiers in Medicine

Article Title: Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis

doi: 10.3389/fmed.2018.00124

Figure Lengend Snippet: Changing taxonomy of probiotic strains over time.

Article Snippet: Florastor ® , Saccharomyces cerevisiae boulardii S. boulardii lyo S. boulardii 17 S. boulardii Hansen CBS-5926 , S. boulardii CNCM I-745 (ATCC 74012).

Techniques:

Journal: Frontiers in Medicine

Article Title: Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis

doi: 10.3389/fmed.2018.00124

Figure Lengend Snippet: Example of forest plot from an appropriate meta-analysis using probiotic strain subgroup analysis for the prevention of Clostridium difficile infections modified from Lau and Chamberlain . Grouping by the same probiotic strain determined that Lactobacillus rhamnosus GG was ineffective, S. boulardii was effective, and only two mixtures were significantly effective . Abbreviations: ID, identification; CI, confidence interval; RR, relative risk; S. boulardii, Saccharomyces boulardii CNCM I-745; L ., Lactobacillus ; L acid + Bifid bifidum, Lactobacillus acidophilus and Bifidobacterium bifidum strains not reported; L acid + L. casei + L. rhamn, L. acidophilus CL1285 + L. casei LBC80R + L. rhamnosus CLR2, Bio-K+ ® .

Article Snippet: Florastor ® , Saccharomyces cerevisiae boulardii S. boulardii lyo S. boulardii 17 S. boulardii Hansen CBS-5926 , S. boulardii CNCM I-745 (ATCC 74012).

Techniques: Modification

Journal: Frontiers in Medicine

Article Title: Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis

doi: 10.3389/fmed.2018.00124

Figure Lengend Snippet: Strength of efficacy for probiotics with identified strain designations and at least two randomized, controlled trials with significant findings for the prevention or treatment of disease.

Article Snippet: Florastor ® , Saccharomyces cerevisiae boulardii S. boulardii lyo S. boulardii 17 S. boulardii Hansen CBS-5926 , S. boulardii CNCM I-745 (ATCC 74012).

Techniques: Probiotics, Clinical Proteomics

Journal: Foods

Article Title: Characteristics of Probiotic Preparations and Their Applications

doi: 10.3390/foods11162472

Figure Lengend Snippet: Recent studies of different carriers for the targeted delivery of probiotics.

Article Snippet: Saccharomyces boulardii ATCC MYA-796 , Alginate and alginate–chitosan , Microcapsule , The survival rates of alginate- and alginate–chitosan-microencapsulated yeast were 80% and 90% after 240 h of treatment with simulated gastric fluid and 80% and 85% after 240 h of treatment with simulated intestinal fluid. , [ ] .

Techniques: Probiotics, Starch, Encapsulation, Polymer, Concentration Assay, Bacteria

Journal: Toxins

Article Title: Patulin in Apples and Apple-Based Food Products: The Burdens and the Mitigation Strategies

doi: 10.3390/toxins10110475

Figure Lengend Snippet: Effect of biocontrol agents on patulin degradation.

Article Snippet: Yeast , Saccharomyces cerevisiae , S288C; obtained from ATCC (ATCC no. 204508) , Fermentation broth, 3.8 mg/L to 0 mg/L , 3.8 ppm PAT; Static Culture, 30 °C, 110 h , E -ascladiol and Z -ascladiol , ND , [ ] .

Techniques: Isolation, Adsorption, Bacteria, Probiotics, Binding Assay

Journal: International Journal of Veterinary Science and Medicine

Article Title: Dietary administration of probiotics modulates non-specific immunity and gut microbiota of Nile tilapia ( Oreochromis niloticus ) cultured in low input ponds

doi: 10.1080/23144599.2019.1624299

Figure Lengend Snippet: Ingredient composition and chemical proximate composition of the experimental diets.

Article Snippet: Different experimental diets were prepared by supplementing the control diet with dietary commercial probiotic Saccharomyces cerevisiae a (1 × 10 10 CFU g −1 ) FURAHA ® (Agro-Chemical and Food Company Limited, Kenya) at 3 concentrations of 2 g kg −1 (Diet 1); 4 g kg −1 (Diet 2) and 6 g kg −1 (Diet 3); and Bacillus subtilis b (1 × 10 9 CFU g −1 ) ULTRALACT ® (Gee Dee Enterprises, India) at 3 concentrations of 5 g kg −1 (Diet 4); 10 g kg −1 (Diet 5) and 15 g kg −1 (Diet 6) according to Abdel-Tawwab et al. [ ] and Hai [ ].

Techniques: Control

Journal: International Journal of Veterinary Science and Medicine

Article Title: Dietary administration of probiotics modulates non-specific immunity and gut microbiota of Nile tilapia ( Oreochromis niloticus ) cultured in low input ponds

doi: 10.1080/23144599.2019.1624299

Figure Lengend Snippet: Hemato-immunological parameters of O. niloticus fed on S. cerevisiae and B. subtilis treated diets in low input ponds.

Article Snippet: Different experimental diets were prepared by supplementing the control diet with dietary commercial probiotic Saccharomyces cerevisiae a (1 × 10 10 CFU g −1 ) FURAHA ® (Agro-Chemical and Food Company Limited, Kenya) at 3 concentrations of 2 g kg −1 (Diet 1); 4 g kg −1 (Diet 2) and 6 g kg −1 (Diet 3); and Bacillus subtilis b (1 × 10 9 CFU g −1 ) ULTRALACT ® (Gee Dee Enterprises, India) at 3 concentrations of 5 g kg −1 (Diet 4); 10 g kg −1 (Diet 5) and 15 g kg −1 (Diet 6) according to Abdel-Tawwab et al. [ ] and Hai [ ].

Techniques: Activity Assay

Journal: International Journal of Veterinary Science and Medicine

Article Title: Dietary administration of probiotics modulates non-specific immunity and gut microbiota of Nile tilapia ( Oreochromis niloticus ) cultured in low input ponds

doi: 10.1080/23144599.2019.1624299

Figure Lengend Snippet: The microbial content of muscle of O. niloticus fed on S. cerevisiae and B. subtilis treated diets in low input ponds.

Article Snippet: Different experimental diets were prepared by supplementing the control diet with dietary commercial probiotic Saccharomyces cerevisiae a (1 × 10 10 CFU g −1 ) FURAHA ® (Agro-Chemical and Food Company Limited, Kenya) at 3 concentrations of 2 g kg −1 (Diet 1); 4 g kg −1 (Diet 2) and 6 g kg −1 (Diet 3); and Bacillus subtilis b (1 × 10 9 CFU g −1 ) ULTRALACT ® (Gee Dee Enterprises, India) at 3 concentrations of 5 g kg −1 (Diet 4); 10 g kg −1 (Diet 5) and 15 g kg −1 (Diet 6) according to Abdel-Tawwab et al. [ ] and Hai [ ].

Techniques:

Journal: International Journal of Veterinary Science and Medicine

Article Title: Dietary administration of probiotics modulates non-specific immunity and gut microbiota of Nile tilapia ( Oreochromis niloticus ) cultured in low input ponds

doi: 10.1080/23144599.2019.1624299

Figure Lengend Snippet: Gut microbiota of O. niloticus fed on S. cerevisiae and B. subtilis treated diets in low input ponds.

Article Snippet: Different experimental diets were prepared by supplementing the control diet with dietary commercial probiotic Saccharomyces cerevisiae a (1 × 10 10 CFU g −1 ) FURAHA ® (Agro-Chemical and Food Company Limited, Kenya) at 3 concentrations of 2 g kg −1 (Diet 1); 4 g kg −1 (Diet 2) and 6 g kg −1 (Diet 3); and Bacillus subtilis b (1 × 10 9 CFU g −1 ) ULTRALACT ® (Gee Dee Enterprises, India) at 3 concentrations of 5 g kg −1 (Diet 4); 10 g kg −1 (Diet 5) and 15 g kg −1 (Diet 6) according to Abdel-Tawwab et al. [ ] and Hai [ ].

Techniques: